Evidence map›Paper›PMID 31811871›Full record

ArticleNeurotoxicology2020

Susceptibility of larval zebrafish to the seizurogenic activity of GABA type A receptor antagonists.

Suren B Bandara, Dennis R Carty, Vikrant Singh, Danielle J Harvey, Natalia Vasylieva, Brandon Pressly, Heike Wulff, Pamela J Lein

Open access · greenAbstract read
In one paragraph

Article in Neurotoxicology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Suren B BandaraDepartment of Molecular Biosciences, University of California, Davis, School of Veterinary Medicine, Davis, CA 95616, United States. Electronic address: sbandara@ucdavis.edu.
Dennis R CartyDepartment of Molecular Biosciences, University of California, Davis, School of Veterinary Medicine, Davis, CA 95616, United States. Electronic address: drcarty@ucdavis.edu.
Vikrant SinghDepartment of Pharmacology, University of California, Davis, School of Medicine, Davis, CA 95616, United States. Electronic address: vssingh@ucdavis.edu.
Danielle J HarveyDepartment of Public Health Sciences, University of California, Davis, School of Medicine, Davis, CA 95616, United States. Electronic address: djharvey@ucdavis.edu.
Natalia VasylievaDepartment of Entomology, University of California, Davis, College of Agricultural and Environmental Sciences, Davis, CA 95616, United States. Electronic address: nvasylieva@ucdavis.edu.
Brandon PresslyDepartment of Pharmacology, University of California, Davis, School of Medicine, Davis, CA 95616, United States. Electronic address: bpressly@ucdavis.edu.
Heike WulffDepartment of Pharmacology, University of California, Davis, School of Medicine, Davis, CA 95616, United States. Electronic address: hwulff@ucdavis.edu.
Pamela J LeinDepartment of Molecular Biosciences, University of California, Davis, School of Veterinary Medicine, Davis, CA 95616, United States. Electronic address: pjlein@ucdavis.edu.
University of California, Davis · US

Funding

UC Davis Clinical and Translational Science CenterUL1TR001860 · NCATS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI KENYON, NICHOLAS J., LYLES, COURTNEY REES · 2016 to 2025
$47.3M
Training and Education CoreU54NS079202 · NINDS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI LEIN, PAMELA J · 2012 to 2021
$35.7M
UC Davis CTSC TL1 Administrative Supplement to Recognize Excellence in Diversity, Equity, Inclusion, and Accessibility MentorshipTL1TR001861 · NCATS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI MEDICI, VALENTINA · 2016 to 2025
$4.7M
Predoctoral Training in Pharmacological SciencesT32GM099608 · NIGMS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI HELL, JOHANNES W · 2012 to 2021
$2.2M
Identifying Molecular Targets for the Proconvulsant Activity of TETSR21NS110647 · NINDS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI LEIN, PAMELA J, WULFF, HEIKE · 2019 to 2020
$414k
NCATS NIH HHS TL1 TR001861NCATS NIH HHS UL1 TR001860NIGMS NIH HHS T32 GM099608NINDS NIH HHS R21 NS110647NINDS NIH HHS U54 NS079202
6 · The paper itself

Abstract

Previous studies demonstrated that pentylenetetrazole (PTZ), a GABA type A receptor (GABA

Indexed as

AnimalsBrainBridged-Ring CompoundsDrug Evaluation, PreclinicalGABA-A Receptor AntagonistsPentylenetetrazolePicrotoxinSeizuresZebrafishBridged-Ring CompoundsGABA-A Receptor AntagonistsPentylenetetrazolePicrotoxintetramethylenedisulfotetramineChemical threat agentsPicrotoxinSeizuresTetramethylenedisulfotetramineTETSZebrafish

Identifiers

PMID31811871
PMCPMC6957304
OpenAlexW2991809425

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.